Multikinase inhibitors

NAT 200 Pill - peach round

Pill with imprint NAT 200 is Peach, Round and has been identified as Sorafenib 200 mg. It is supplied by Mylan Pharmaceuticals Inc.

Sorafenib is used in the treatment of Hepatocellular Carcinoma; Hepatic Tumor; Renal Cell Carcinoma; Thyroid Cancer and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Sorafenib 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Sorafenib (Sorafenib [ sor-a-fen-ib ])-NAT 200-200 mg-Peach-Round

Sorafenib
Generic Name: sorafenib [ sor-a-fen-ib ]
Imprint: NAT 200
Strength: 200 mg
Color: Peach
Size: N/A
Shape: Round
Availability: Prescription only
Drug Class: Multikinase inhibitors VEGF/VEGFR inhibitors
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 00378-1201
Inactive Ingredients:
Latest News
Related Drugs